Division of Interventional Radiology, Department of Radiology, Section of Interventional Radiology, Northwestern Memorial Hospital, 676 N. St. Clair, Suite 800, Chicago, IL, 60611, USA.
Department of Surgery, Northwestern Memorial Hospital, Chicago, IL, USA.
Cardiovasc Intervent Radiol. 2024 Aug;47(8):1083-1092. doi: 10.1007/s00270-024-03778-x. Epub 2024 Jun 10.
This study aimed to present the institutional experience and algorithm for performing biliary interventions in liver transplant patients using the modified Hutson loop access (MHLA) and the impact of percutaneous endoscopy via the MHLA on these procedures.
Over 13 years, 201 MHLA procedures were attempted on 52 patients (45 liver transplants; 24 living and 21 deceased donors) for diagnostic (e.g., cholangiography) and therapeutic (e.g., stent/drain insertion and cholangioplasty) purposes. The most common indications for MHLA were biliary strictures (60%) and bile leaks (23%). Percutaneous endoscopy was used to directly visualize the biliary-enteric anastomosis, diagnose pathology (e.g., ischemic cholangiopathy), and help in biliary hygiene (removing debris/casts/stones/stents) in 138/201 (69%) procedures. Technical success was defined as cannulating the biliary-enteric anastomosis and performing diagnostic/therapeutic procedure via the MHLA.
The technical success rate was 95% (190/201). The failure rate among procedures performed with and without endoscopy was 2% (3/138) versus 13% (8/63) (P = 0.0024), and the need for new transhepatic access (to aid the procedure) was 12% (16/138) versus 30% (19/63) (P = 0.001). Despite endoscopy, failure in 2% of the cases resulted from inflamed/friable anastomosis (1/3) and high-grade stricture (2/3) obstructing retrograde cannulation of biliary-enteric anastomosis. Major adverse events (bowel perforation and injury) occurred in 1% of the procedures, with no procedure-related mortality.
MHLA-based percutaneous biliary intervention is a safe and effective alternative to managing complications after liver transplant. Percutaneous endoscopy via the MHLA improves success rates and may reduce the need for new transhepatic access. Level of Evidence Level 4.
本研究旨在介绍使用改良 Hutson 环入路(MHLA)进行肝移植患者胆道介入治疗的机构经验和算法,以及通过 MHLA 进行经皮内镜检查对这些操作的影响。
在 13 年多的时间里,52 名患者(45 例肝移植;24 例活体和 21 例已故供体)进行了 201 次 MHLA 操作,用于诊断(如胆管造影)和治疗(如支架/引流管插入和胆管成形术)。MHLA 的最常见适应证是胆管狭窄(60%)和胆漏(23%)。经皮内镜用于直接观察胆肠吻合口,诊断病理学(如缺血性胆管病),并在 138/201 例(69%)操作中帮助胆道卫生(清除碎片/铸型/结石/支架)。技术成功定义为经 MHLA 胆管-肠吻合口穿刺并进行诊断/治疗操作。
技术成功率为 95%(190/201)。有和没有内镜的操作失败率分别为 2%(3/138)和 13%(8/63)(P=0.0024),需要新的经肝入路(以辅助操作)的比例分别为 12%(16/138)和 30%(19/63)(P=0.001)。尽管进行了内镜检查,但由于吻合口炎症/脆弱(1/3)和高等级狭窄(2/3)阻碍逆行胆管-肠吻合口穿刺,仍有 2%的病例操作失败。主要不良事件(肠穿孔和损伤)发生在 1%的操作中,无与操作相关的死亡。
基于 MHLA 的经皮胆道介入治疗是治疗肝移植后并发症的一种安全有效的替代方法。通过 MHLA 进行经皮内镜检查可提高成功率,并可能减少对新经肝入路的需求。证据等级 4 级。